INPP5D limits plaque formation and glial reactivity in the APP/PS1 mouse model of Alzheimer’s disease

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Researchers identify the role of an Alzheimer's disease risk gene in the brain mountsinainyc

The dual specificity lipid/protein phosphatase SHIP1 is enriched in myeloid cells. Single nucleotide polymorphisms incoding and non-coding regions impact risk for developing late onset sporadic Alzheimer’s disease .

We present pathological analyses with spatial transcriptomics of mice with tamoxifen-sensitive microglial knockdown ofand show exacerbated plaque pathology, plaque-associated microglial density, and altered gene expression around plaques, suggesting novel markers for plaque-associated reactive microglia.SAL is a founder of AstronauTx Ltd. All other others declare no competing interests.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

INPP5D limits plaque formation and glial reactivity in the APP/PS1 mouse model of Alzheimer’s diseaseThe dual specificity lipid/protein phosphatase SHIP1 (encoded by the INPP5D gene) is enriched in myeloid cells. Single nucleotide polymorphisms (SNPs) in INPP5D coding and non-coding regions impact risk for developing late onset sporadic Alzheimer’s disease (LOAD). We present pathological analyses with spatial transcriptomics of mice with tamoxifen-sensitive microglial knockdown of Inpp5d and show exacerbated plaque pathology, plaque-associated microglial density, and altered gene expression around plaques, suggesting novel markers for plaque-associated reactive microglia. Competing Interest Statement SAL is a founder of AstronauTx Ltd. All other others declare no competing interests.
Source: medical_xpress - 🏆 101. / 51 Read more »